INDEPENDENT PERSPECTIVES ON WHOLE-PERSON HEALTHSearch the Journal ↗
Wholistic Health Journal
NEWS, PROVIDERS, AND DESTINATIONS FOR WHOLE-PERSON HEALTH
Sections & searchAll news & research
News
All news & research →

Approaches to care

Whole-person & integrative careHerbs & supplementsAcupuncture & Chinese medicineAyurveda, yoga & traditional approachesFunctional & lifestyle medicineBodywork & somatic practicesRegenerative & emerging scienceNaturopathy & natural healthHomeopathyEnergy practices & ReikiChiropractic careOsteopathic medicineColon hydrotherapyDetoxification & fastingHealth coaching & wellness consultingBreathwork

Everyday wellness

Nutrition & plant-based livingMind-body & mental healthLongevity & healthy agingSleep & stressMovement & recovery

Health conditions

Cancer & supportive careDiabetes & metabolic healthHeart & cardiovascular healthBrain & cognitive healthImmune & autoimmune healthGut & digestive health

Health through life

Women’s & reproductive healthMen’s health

Environment & prevention

Environmental health & moldLyme, ticks & infectious disease

Destinations

Wellness destinations
RSS source directory →
Health & Wellness TopicsFind a ProviderFeatured Providers by StateWellness DestinationsGet MatchedFor ProvidersSearch

NEWS BRIEF · Research journal

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials

Source: Nature Medicine · Source publication date:

From the report

Nature Medicine, Published online: 02 November 2026; doi:10.1038/s41591-026-04739-2In the STOP-V1 and STOP-V2 trials, povorcitinib (an oral JAK1 inhibitor) was superior to placebo in improvement in F-VASI75 score in individuals with nonsegmental vitiligo.

Continue reading

All news →